Quidelortho CORP Schedule 13G passive stakes

T. Rowe Price Investment Management, Inc. has updated its beneficial ownership filing for QuidelOrtho Corp., reporting a 2.6% stake.

Invesco Ltd. has reported beneficial ownership of 5.1% of QuidelOrtho Corp's common stock as of June 30, 2026.

Neuberger Berman Group LLC and its affiliate Neuberger Berman Investment Advisers LLC have updated their beneficial ownership filing for QuidelOrtho Corp, reporting a combined 4.9% stake.

Neuberger Berman Group LLC and its affiliates have reported beneficial ownership of 5.2% of QuidelOrtho Corp's common stock as of June 30, 2026.

FMR LLC, through its subsidiaries, has reported a beneficial ownership of 11.5% of QuidelOrtho Corp's common stock as of April 30, 2026.

Invesco Ltd. has filed an amendment to its Schedule 13G, disclosing a 4.6% beneficial ownership stake in QuidelOrtho Corp.

Newtyn Management, LLC and its affiliate Newtyn TE Partners, LP have filed an amended Schedule 13G, reporting a combined beneficial ownership of 7.8% of QuidelOrtho Corporation's common stock.

Newtyn Management, LLC has reported beneficial ownership of 4,558,472 shares, representing 6.7% of QuidelOrtho Corporation's common stock as of March 31, 2026.

FMR LLC, along with Abigail P. Johnson, has filed a Schedule 13G, reporting beneficial ownership of 9.7% of QuidelOrtho Corp's common stock as of March 31, 2026.

Vanguard Capital Management reports beneficial ownership of over 3.57 million shares, representing 5.24% of QuidelOrtho Corp's common stock as of March 31, 2026.

Vanguard Portfolio Management has reported beneficial ownership of 6% of QuidelOrtho Corp's common stock as of March 31, 2026.

T. Rowe Price Investment Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 8.3% of QuidelOrtho Corp.'s common stock as of March 31, 2026.

The Vanguard Group reports 0% beneficial ownership in QuidelOrtho Corp following an internal realignment, with subsidiaries now reporting separately.

Rubric Capital Management LP and David Rosen have reported a beneficial ownership of 5.56% in QuidelOrtho Corporation's common stock.

Invesco Ltd. has reported a 5.1% beneficial ownership stake in QuidelOrtho Corp., holding 3,470,656 shares of common stock as of December 31, 2025.

FMR LLC and Abigail P. Johnson have reported an 8.0% beneficial ownership stake in QuidelOrtho Corp, totaling over 5.4 million common shares.

FMR LLC and its affiliates, along with Abigail P. Johnson, reported a 6.6% beneficial ownership stake in QuidelOrtho Corp. common stock as of September 30, 2025.

Invesco Ltd. has disclosed a 2.3% beneficial ownership stake in QuidelOrtho Corp, holding 1,554,260 shares of common stock.

The Vanguard Group has filed an Amendment No. 5 to its Schedule 13G, disclosing a beneficial ownership of 11.52% in QuidelOrtho Corp's Common Stock as of June 30, 2025.

BlackRock, Inc. has increased its beneficial ownership in QuidelOrtho Corp's common stock to 14.8%, holding 9,995,336 shares as of June 30, 2025.

Rubric Capital Management LP and David Rosen have reported a passive beneficial ownership of 6.86% in QuidelOrtho Corporation's common stock, totaling 4,637,738 shares.

T. Rowe Price Investment Management, Inc. has filed an amended Schedule 13G, confirming its passive beneficial ownership of 16.7% of QuidelOrtho Corp's common stock as of December 31, 2024.

Rubric Capital Management LP and its managing member, David Rosen, have disclosed a beneficial ownership of 8.25% in QuidelOrtho Corp's common stock.

Invesco Ltd. has reported a 5.1% passive beneficial ownership stake in QuidelOrtho Corp, holding 3,447,446 shares as of December 31, 2024.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 12.5% beneficial ownership stake in QuidelOrtho Corp. as of December 31, 2024.